Effects of lactate-buffered and lactate-free dialysate in CAVHD patients with and without liver dysfunction  Adam G. McLean, Andrew Davenport, Dominic.

Slides:



Advertisements
Similar presentations
Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.
Advertisements

Kamyar Kalantar-Zadeh  Kidney International 
Volume 64, Issue 4, Pages (October 2003)
Extending Metformin Use in Diabetic Kidney Disease: A Pharmacokinetic Study in Stage 4 Diabetic Nephropathy  Ajith Munasinghe Dissanayake, Mark Christopher.
Volume 88, Issue 5, Pages (November 2015)
Plasma sodium and hypertension
Buffer transport in peritoneal dialysis
Propofol-related green urine
Recalcitrant pain in a patient with ADPKD
Volume 56, Pages S95-S98 (November 1999)
Volume 56, Pages S62-S66 (November 1999)
Confounding: What it is and how to deal with it
Volume 54, Pages S86-S91 (December 1998)
Volume 53, Issue 4, Pages (April 1998)
Zaccaria Ricci, Claudio Ronco, Sergio Picardo  Kidney International 
Prehypertension and chronic kidney disease: the ox or the plow?
Continuous renal replacement therapy in the critically ill patient
Dieter A. Häberle, Wolfgang Biller, Takuyuki Ise, Christian J. Metz 
Volume 75, Issue 11, Pages (June 2009)
Section 5: Dialysis Interventions for Treatment of AKI
Volume 77, Issue 1, Pages 6-8 (January 2010)
The myogenic response in uremic hypertension
Volume 58, Issue 4, Pages (October 2000)
Kamyar Kalantar-Zadeh  Kidney International 
Peripheral microvascular parameters in the nephrotic syndrome
Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy?  Fu L. Luan, Diane E. Steffick,
Metformin and other antidiabetic agents in renal failure patients
Volume 64, Issue 4, Pages (October 2003)
Methotrexate in the urine
Volume 54, Issue 4, Pages (October 1998)
Volume 71, Issue 11, Pages (June 2007)
Volume 87, Issue 2, Pages (February 2015)
Volume 66, Issue 1, Pages (July 2004)
Elke Wühl, Otto Mehls, Franz Schaefer  Kidney International 
Blood pressure targets in hemodialysis patients
Volume 57, Issue 2, Pages (October 2000)
Joel D. Kopple, Kamyar Kalantar-Zadeh, Rajnish Mehrotra 
Hemodialysis arteriovenous access: Detection of stenosis and response to treatment by vascular access blood flow  Steve J. Schwab, Matthew J. Oliver,
Volume 76, Issue 6, Pages (September 2009)
Volume 85, Issue 3, Pages (March 2014)
Cardiac arrest and sudden death in dialysis units
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia 
Randomized long-term evaluation of bicarbonate-buffered CAPD solution
Volume 87, Issue 1, Pages (January 2015)
Nephrology Crossword: Glomerulonephritis
Circadian regulation of renal function
Volume 87, Issue 5, Pages (May 2015)
Joachim Böhler, M.D., Johannes Donauer, Frieder Keller 
Serum cystatin C-immunoglobulin high-molecular-weight complexes in kidney and liver transplant patients  Jesús Hermida, Rafael Romero, J. Carlos Tutor 
The course of the remnant kidney model in mice
Organ transplantation goes to the movies
David Z. Levine, M.D., Michelle Iacovitti, Kevin D. Burns, Amy Slater 
Role of sodium in hemodialysis
Volume 80, Issue 10, Pages (November 2011)
Is it the low-protein diet or simply the salt restriction?
Charles A. Herzog  Kidney International 
Replacing the short ammonium chloride test
Volume 70, Issue 3, Pages (August 2006)
Importance of blood pressure control in hemodialysis patient survival
Volume 70, Issue 5, Pages (September 2006)
Volume 56, Issue 4, Pages (October 1999)
H.J. Chin, H. Ro, H.J. Lee, K.Y. Na, D.-W. Chae  Kidney International 
The International Pediatric Peritonitis Registry: Starting to walk
Critical care nephrology: management of acid–base disorders with CRRT
Tetany during bicarbonate loading test
Volume 57, Issue 2, Pages (October 2000)
Laura M. Krinsky, William J. Levine  Kidney International 
Presentation transcript:

Effects of lactate-buffered and lactate-free dialysate in CAVHD patients with and without liver dysfunction  Adam G. McLean, Andrew Davenport, Dominic Cox, Paul Sweny  Kidney International  Volume 58, Issue 4, Pages 1765-1772 (October 2000) DOI: 10.1046/j.1523-1755.2000.00338.x Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 1 Control of acidosis with lactate-free (HCO3- replacement) and lactate-buffered dialysate. (A) Mean and SEM arterial hydrogen ion concentration during the first 24 hours of CRRT against lactate-free (▪) and lactate-buffered (□) dialysate. (B) Mean and SEM arterial hydrogen ion concentration during the first 24 hours of CRRT against lactate-free and lactate-buffered dialysate in patients with severe acidosis (pH < 7.25, [H+]> 56 nmol), moderate acidosis (pH 7.25 to 7.3, [H+] 50 to 56 nmol), and mild acidosis (pH > 7.3, [H+] < 50 nmol). Symbols are: (•) severe, (▪) moderate, (▴) mild lactate-free dialysate; (○) severe, (□) moderate, (▵) mild lactate-buffered dialysate. Kidney International 2000 58, 1765-1772DOI: (10.1046/j.1523-1755.2000.00338.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 2 Changes in blood gas, sodium, buffer, and blood pressure levels with lactate-free (HCO3- replacement) and lactate-buffered dialysate. (A) Blood sodium and arterial blood gas concentration during the first 24 hours of CRRT against lactate-free (▪) and lactate-buffered (□) dialysate. (B) Arterial bicarbonate and L-lactate concentration during the first 24 hours of CRRT against lactate-free (•, ▪) and lactate-buffered (○, □) dialysate. (C) MAP during the first 24 hours of CRRT against lactate-free (▪) and lactate-buffered (□) dialysate. Data are mean and SEM. Kidney International 2000 58, 1765-1772DOI: (10.1046/j.1523-1755.2000.00338.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 3 Correction of acidosis and total buffer administration with lactate-free (HCO3- replacement) and lactate-buffered dialysate. Data are mean and SEM of the extent of correction of acidosis (change in hydrogen ion concentration in nmol) over the first 24 hours of CRRT against lactate-free and lactate-buffered dialysate against the total buffer delivered by the CRRT circuit plus supplementary HCO3-administration. Kidney International 2000 58, 1765-1772DOI: (10.1046/j.1523-1755.2000.00338.x) Copyright © 2000 International Society of Nephrology Terms and Conditions